Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The 2.4 Å structure of Zymomonas mobilis pyruvate kinase: Implications for stability and regulation

Journal Article · · Archives of Biochemistry and Biophysics
 [1];  [2];  [2];  [1];  [3];  [3];  [1]
  1. University of Texas, San Antonio, TX (United States)
  2. University of Kansas, Lawrence, KS (United States)
  3. University of Kansas Medical Center, Kansas City, KS (United States)
Human liver pyruvate kinase (hlPYK) catalyzes the final step in glycolysis, the formation of pyruvate (PYR) and ATP from phosphoenolpyruvate (PEP) and ADP. Fructose 1,6-bisphosphate (FBP), a pathway intermediate of glycolysis, serves as an allosteric activator of hlPYK. Zymomonas mobilis pyruvate kinase (ZmPYK) performs the final step of the Entner-Doudoroff pathway, which is similar to glycolysis in that energy is harvested from glucose and pyruvate is generated. The Entner-Doudoroff pathway does not have FBP as a pathway intermediate, and ZmPYK is not allosterically activated. In this work, we solved the 2.4 Å X-ray crystallographic structure of ZmPYK. The protein is dimeric in solution as determined by gel filtration chromatography, but crystallizes as a tetramer. The buried surface area of the ZmPYK tetramerization interface is significantly smaller than that of hlPYK, and yet tetramerization using the standard interfaces from higher organisms provides an accessible low energy crystallization pathway. Interestingly, the ZmPYK structure showed a phosphate ion in the analogous location to the 6-phosphate binding site of FBP in hlPYK. Circular Dichroism (CD) was used to measure melting temperatures of hlPYK and ZmPYK in the absence and presence of substrates and effectors. The only significant difference was an additional phase of small amplitude for the ZmPYK melting curves. We conclude that the phosphate ion plays neither a structural or allosteric role in ZmPYK under the conditions tested. In conclusion, we hypothesize that ZmPYK does not have sufficient protein stability for activity to be tuned by allosteric effectors as described for rheostat positions in the allosteric homologues.
Research Organization:
SLAC National Accelerator Laboratory, Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
Sponsoring Organization:
American Heart Association Predoctoral Fellowship; National Institutes of General Medical Sciences; National Institutes of Health (NIH); National Institutes of Health Graduate Training Program in the Dynamic Aspects of Chemical Biology Grant; USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-76SF00515
OSTI ID:
2423941
Alternate ID(s):
OSTI ID: 1989277
Journal Information:
Archives of Biochemistry and Biophysics, Journal Name: Archives of Biochemistry and Biophysics Vol. 744; ISSN 0003-9861
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (39)

Are all regions of folded proteins that undergo ligand‐dependent order–disorder transitions targets for allosteric peptide mimetics? journal November 2013
Benchmarking predictions of allostery in liver pyruvate kinase in CAGI4 journal May 2017
Whole‐protein alanine‐scanning mutagenesis of allostery: A large percentage of a protein can contribute to mechanism journal June 2017
RheoScale: A tool to aggregate and quantify experimentally determined substitution outcomes for multiple variants at individual protein positions journal August 2018
Rheostat functional outcomes occur when substitutions are introduced at nonconserved positions that diverge with speciation journal June 2021
Substitutions at a rheostat position in human aldolase A cause a shift in the conformational population journal November 2021
Identification of biochemically neutral positions in liver pyruvate kinase journal June 2020
Allosteric Regulation of Human Liver Pyruvate Kinase by Peptides that Mimic the Phosphorylated/Dephosphorylated N-Terminus book September 2011
Identification of Allosteric-Activating Drug Leads for Human Liver Pyruvate Kinase book September 2011
Rheostat positions: A new classification of protein positions relevant to pharmacogenomics journal June 2020
Evolution of carbohydrate metabolic pathways journal July 1996
The Control of Pyruvate Kinases of Escherichia coli journal January 1974
Cloning and expression of the Zymomonas mobilis pyruvate kinase gene in Escherichia coli journal October 1998
The pH dependence of the allosteric response of human liver pyruvate kinase to fructose-1,6-bisphosphate, ATP, and alanine journal April 2009
The phosphate moiety of phosphoenolpyruvate does NOT contribute to allosteric regulation of liver pyruvate kinase by fructose-1,6-bisphosphate✝ journal November 2020
A critical review of the role of M2PYK in the Warburg effect journal April 2019
What Mutagenesis Can and Cannot Reveal About Allostery journal June 2016
Chokepoints in Mechanical Coupling Associated with Allosteric Proteins: The Pyruvate Kinase Example journal May 2019
Central carbon metabolism ofLeishmaniaparasites journal February 2010
Effector Analogues Detect Varied Allosteric Roles for Conserved Protein−Effector Interactions in Pyruvate Kinase Isozymes journal March 2011
Energetic Coupling between an Oxidizable Cysteine and the Phosphorylatable N-Terminus of Human Liver Pyruvate Kinase journal January 2013
Distinguishing the Interactions in the Fructose 1,6-Bisphosphate Binding Site of Human Liver Pyruvate Kinase That Contribute to Allostery journal February 2015
An Activating Interaction between the Unphosphorylated N-Terminus of Human Liver Pyruvate Kinase and the Main Body of the Protein Is Interrupted by Phosphorylation journal April 2009
The genome sequence of the ethanologenic bacterium Zymomonas mobilis ZM4 journal December 2004
Mutational mimics of allosteric effectors: a genome editing design to validate allosteric drug targets journal June 2019
Isolation and properties of the glycolytic enzymes from Zymomonas mobilis. The five enzymes from glyceraldehyde-3-phosphate dehydrogenase through to pyruvate kinase journal August 1986
Glucose metabolism in Trypanosoma cruzi journal October 2011
A clinically relevant polymorphism in the Na+/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position journal January 2021
Mining for allosteric information: Natural mutations and positional sequence conservation in pyruvate kinase journal January 2006
funtrp: identifying protein positions for variation driven functional tuning journal October 2019
Phaser crystallographic software journal July 2007
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions journal November 2004
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Data processing and analysis with the autoPROC toolbox journal March 2011
Blu-Ice and the Distributed Control System : software for data acquisition and instrument control at macromolecular crystallography beamlines journal November 2002
Changes in the allosteric site of human liver pyruvate kinase upon activator binding include the breakage of an intersubunit cation–π bond journal June 2019
The biology of Zymomonas. journal January 1977

Similar Records

Structural Investigation of a Dimeric Variant of Pyruvate Kinase Muscle Isoform 2
Journal Article · Mon Nov 27 19:00:00 EST 2017 · Biochemistry · OSTI ID:1423366

An overview of structure, function, and regulation of pyruvate kinases
Journal Article · Sun Aug 11 20:00:00 EDT 2019 · Protein Science · OSTI ID:1556813